Wockhardt moves HC against ban on its fixed dose combination drug

Wockhardt moved the court as its anti-inflammatory drug -- Ace Proxyvon -- is one of the FDC medicines affected by the Centre's September 7 notification banning 328 such combinations

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2p8HhVO
via IFTTT